The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImmupharma Regulatory News (IMM)

Share Price Information for Immupharma (IMM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.16
Bid: 2.09
Ask: 2.20
Change: -0.055 (-2.50%)
Spread: 0.11 (5.263%)
Open: 2.07
High: 2.16
Low: 2.07
Prev. Close: 2.20
IMM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

27 May 2005 13:29

General Industries PLC27 May 2005 GENERAL INDUSTRIES PLC PRELIMINARY RESULTS FOR THE YEAR ENDED 31 MARCH 2005 HIGHLIGHTS Net cash of £1,005,312 (2004: £978,202) Profit before taxation £16,637 (13 months ended 31 March 2004: £2,400) Earnings per share £0.36 (13 months ended 31 March 2004: £0.07) Richard Wollenberg, chairman, commented: Chairman Richard Wollenberg said "during the year potential acquisitions in theself-storage, property management, social housing services, informationtechnology and business communications sectors have been assessed, as well asother sectors of the market, but the directors considered that the finalpropositions did not meet the directors' criteria". For further information: General Industries plc Richard Wollenberg 01784 437444KBC Peel Hunt Jonathan Marren 020 7418 8900 General Industires plc Preliminary results for the period ending 31 March 2004 Chairman's StatementGeneral Industries was formed to provide the opportunity of financing one ormore growing unquoted companies wishing to seek capital for the expansion oftheir business and a public market for their shares.During the year potential acquisitions in the self storage, property management,social housing services and business communications sector have been assessed,as well as other sectors of the market, but your directors considered that thefinal propositions did not meet your directors' criteria. FinancialAs at 31 March 2005 the company's cash deposits amounting to £1,005,312 (2004:£978,202) were placed on short term bank deposit with the interest rate linkedto base rate.Turnover for the period under review was £nil (13 months ended 31 March 2004:£nil) and will remain so until an acquisition is completed. Profit before taxfor the year was £16,637 (thirteen months ended 31 March 2004: £2,400) whichrelated entirely to interest received from cash on deposit less the cost ofcarrying out due diligence on a specific acquisition and the expenses of runningan AIM listed company. Earnings per share were 0.36p (thirteen months ended 31March 2004: 0.07p). Annual running costs and any outside costs of due diligencewill continue to remain minimal until such time as an acquisition is identified. DividendAs previously stated the directors do not intend to declare a dividend in theshort term. OutlookYour directors are investigating a number of companies but have recently foundunrealistic price expectations being placed by owners or shareholders on theircompanies.A re-rating of the smaller companies sector has certainly been apparent over thepast six months and whilst this has been taken into consideration, yourdirectors are unwilling to chase valuations and potentially overpay inanticipation of future earnings.Your directors will continue to seek a suitable acquisition in line with thestrategy set out in the company's prospectus. J Richard Wollenberg 27 May 2005 Profit and Loss Accountfor the year ended 31 March 2005 Notes Year ended 13 months ended 31 March 2005 31 March 2004 £ £Administrative expenses being operatingloss and loss on ordinary activitiesbefore interest (28,774) (14,560) Interest receivable and similar income 2 45,411 16,960 ------------ -------------- Profit on ordinary activities beforetaxation 3-4 16,637 2,400Tax on profit on ordinary activities 5 (1,576) (1,023) ------------ -------------- Profit on ordinary activities aftertaxation being profit for the financialyear 15,061 1,377 ============ ============== Earnings per share Year ended 13 months 31 ended March 2005 31 March 2004 Pence per Pence per Share shareOn profit for the financial periodBasic 0.36 0.07Diluted 0.36 0.07 ============ ============== The above results relate entirely to continuing activities. There were noacquisitions or disposals of businesses in the period. The profit for thefinancial period represents the total gains and losses and the total historicalcost profit recognised for the period. Balance Sheetat 31 March 2005 Notes At 31 March At 31 March 2005 2004 £ £Current assetsDebtors 8 1,806 1,718Cash at bank and in hand 1,005,312 978,202 ------------ -------------- 1,007,118 979,920Creditors: amounts falling duewithin one year 9 (13,677) (1,540) ------------ -------------- Net current assets being totalassets less current liabilitiesand net assets 993,441 978,380 ============ ============== Capital and reserves ===Called up share capital 10 420,000 420,000Share premium account 11 557,003 557,003Profit and loss account 12 16,438 1,377 ------------ -------------- Shareholders' funds - equity 13 993,441 978,380 ============ ============== Net assets per share 7 23.7p 23.3p ============ ============== These financial statements were approved by the board of directors on 26 May2005 and were signed on its behalf by: J Richard WollenbergDirector Cash Flow Statementfor the year ended 31 March 2005 Notes Year ended 13 months ended 31 March 2005 31 March 2004 £ £Cash outflow from operating activities (18,301) (15,761)Returns on investment and servicing offinance 15 45,411 16,960 ---------- ----------- Cash inflow before financing 27,110 1,199Financing 15 - 977,002 ---------- ----------- Increase in cash in the period 27,110 978,201 ========== =========== Reconciliation of Net Cash Flow to Movement in Net Funds At 31 March At 31 2005 March 2004 £ £Increase in cash and movement in netfunds in the period resulting fromcash flows 16 27,110 978,201Net funds at beginning of period 16 978,202 1 ----------- ----------- Net funds at end of period 16 1,005,312 978,202 =========== =========== Reconciliation of Operating Loss to Net Cash Outflow from Operating Activities Year ended 13 months ended 31 March 2005 31 March 2004 £ £Operating loss (28,774) (14,560)Increase in debtors (88) (1,718)Increase in creditors 10,561 517 ---------- ----------- Net cash outflow from operating activities (18,301) (15,761) ========== =========== Notes(forming part of the financial statements) 1 Accounting PoliciesThe following principal accounting policies have been applied consistently indealing with items which are considered material in relation to the company'sfinancial statements. The financial statements have been prepared under thehistorical cost convention and in accordance with applicable accountingstandards and with the Companies Act 1985. TaxationProvision is made for corporation tax payable at current rates on profits asadjusted for tax purposes.Deferred tax is recognised, without discounting, in respect of all timingdifferences between the treatment of certain items for taxation and accountingpurposes which have arisen but not reversed by the balance sheet date, except asotherwise required by FRS 19. 2 Interest Receivable and Similar Income Year ended 13 months ended 31 March 2005 31 March 2004 £ £ On bank deposits 45,411 16,960 ========== =========== 3 Directors remuneration and staff costsThe average number of persons employed by the company (including executivedirectors) during the period was: Number of employees Year ended 13 months ended 31 March 2005 31 March 2004Management 2 2 ========== =========== Year ended 13 months ended 31 March 2005 31 March 2004 £ £Directors' emoluments 6,416 nil =========== =========== No retirement benefits are accruing to directors.Information on directors' share options is shown in the report of the directorson page 3. Notes (continued) 4 Profit on Ordinary Activities Before Taxation Year ended 13 months ended 31 March 2005 31 March 2004 £ £This is stated after charging the following:Auditors' remuneration:Audit fees paid to the company's auditors andits associates 1,050 700Tax compliance and other fees paid to thecompany's auditors and its associates 750 4,000 =========== =========== 5 Tax on Profit on Ordinary Activities Year ended 31 13 months ended March 2005 31 March 2004 £ £UK corporation tax at 19% onprofits for the period 1,576 1,023 =========== =========== Factors affecting the current tax charge for the periodThe current tax charge for the period is lower than (thirteen months ended 31March 2004: higher than) the small company rate of corporation tax in the UK of19% (thirteen months ended 31 March 2004: 19%). Year ended 13 months ended 31 March 2005 31 March 2004 £ £Current tax reconciliationProfit on ordinary activities before tax 16,637 2,400 =========== =========== Profit on ordinary activities multiplied bythe lower rate of corporation tax in the UK of19 % (2004: 19%) 3,161 456 Effects ofExpenses not allowed for tax purposes - 567Marginal rate relief (1,585) - ----------- ----------- Current tax charge 1,576 1,023 =========== =========== Notes (continued) 6 Earnings Per ShareEarnings per share has been calculated in accordance with Financial ReportingStandard 14 - Earnings Per Share using the profit after tax for the year of£15,061 (thirteen months ended 31 March 2004: £1,377) and the weighted averagenumber of shares in issue during the period as follows: Weighted average number of shares Year ended 13 months ended 31 March 2005 31 March 2004Basic 4,200,000 1,976,928 ---------- -----------Adjustment to basic for element of shares tobe issued on 40,320 18,609exercise of options ---------- ----------- Diluted basis 4,240,320 1,995,537 ========== =========== 7 Net Assets per Share At 31 March At 31 March 2005 2004 Pence per share Pence per share Based on shares in issue at 31 March 2005of 4,200,000 (2004: 4,200,000) 23.7p 23.3p =========== =========== 8 Debtors At 31 March At 31 March 2005 2004 £ £Prepayments and accrued income 1,806 1,718 =========== =========== 9 Creditors: amounts falling due within one year At 31 March At 31 March 2005 2004 £ £Corporation tax 2,599 1,023Accruals and deferred income 11,078 517 ----------- ----------- 13,677 1,540 Notes (continued) 10 Share Capital At 31 March At 31 March 2005 2004 £ £Authorised20,000,000 (2004: 20,000,000) ordinaryshares of 10 pence each 2,000,000 2,000,000 =========== ============ Allotted, called up and fully paid4,200,000 (2004: 4,200,000) ordinaryshares of 10 pence each 420,000 420,000 =========== ============ Details of share options held by the directors are set out in the report of thedirectors on page 3. At 31 March 2005, by an option Agreement dated 10 October2003, KBC Peel Hunt had been granted an option to subscribe at a price of 25peach per share for 84,000 ordinary shares, which is exercisable within theperiod 10 October 2004 and 10 October 2008. 11 Share Premium Account £At 1 April 2004 and 31 March 2005 557,003 ============ 12 Profit and Loss Account £At 1 April 2004 1,377Retained profit for the financial period 15,061 ------------ At 31 March 2005 16,438 ============ 13 Reconciliation of Movements in Shareholders' Funds At 31 March At 31 March 2005 2004 £ £At 1 April 2004 978,380 1Profit for the financial period 15,061 1,377Share premium on shares issued in period(net of - 557,003expenses)Shares issued in period - 419,999 ----------- ------------ At 31 March 2005 993,441 978,380 =========== ============Notes (continued)14 CommitmentsThere were no commitments under contract at 31 March 2005 (2004: £nil). 15 Gross Cash Flows Year ended 13 months ended 31 March 2005 31 March 2004 £ £Returns on investment and servicing of financeInterest received 45,411 16,960 =========== ============ FinancingShares issued in the period - 1,024,998Expenses of share issue - (47,996) ----------- ------------ - 977,002 =========== ============ 16 Analysis of Net Funds At 31 March Cash flow At 31 March 2005 2004 £ £ £Cash at bank 978,202 27,110 1,005,312 ------------- ----------- ------------ 17 Related Party TransactionsDuring the period the company did not enter into any material transactions withrelated parties. 18The financial information in this announcement does not constitute the company'sstatutory accounts for the year ended 31 March 2005. The statutory accounts forthe year ended 31 March 2005 will be finalised on the basis of the financialinformation presented by the directors in this preliminary announcement and willbe delivered to the Registrar of Companies. It is expected that the accountswill be mailed to shareholders in mid-June. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Jun 20197:00 amRNSNotice of AGM and posting of Report & Accounts
24th May 20197:00 amRNSFINAL RESULTS
7th May 20197:00 amRNSCorporate Update
1st Apr 20197:00 amRNSUpdate on Nucant Cancer Programme
14th Mar 20197:00 amRNSCorporate Update
26th Feb 20197:00 amRNSTechnology review published-Nature Communications
31st Dec 20187:00 amRNSClinical Development Collaboration with Incanthera
21st Dec 20184:41 pmRNSSecond Price Monitoring Extn
21st Dec 20184:36 pmRNSPrice Monitoring Extension
20th Dec 20184:35 pmRNSPrice Monitoring Extension
17th Dec 20187:00 amRNSAppointment of Nominated Adviser
7th Dec 20187:00 amRNSUpdate on Corporate Activities
29th Nov 20184:40 pmRNSSecond Price Monitoring Extn
29th Nov 20184:35 pmRNSPrice Monitoring Extension
28th Nov 20184:40 pmRNSSecond Price Monitoring Extn
28th Nov 20184:35 pmRNSPrice Monitoring Extension
23rd Nov 20184:40 pmRNSSecond Price Monitoring Extn
23rd Nov 20184:35 pmRNSPrice Monitoring Extension
21st Nov 20184:40 pmRNSSecond Price Monitoring Extn
21st Nov 20184:35 pmRNSPrice Monitoring Extension
7th Nov 20184:35 pmRNSPrice Monitoring Extension
1st Nov 20181:38 pmRNSNominated Adviser Status
26th Sep 20187:00 amRNSInterim Results
19th Sep 20187:00 amRNSAppointment of Joint Brokers
7th Sep 20187:00 amRNSCorporate Update
10th Jul 20184:40 pmRNSSecond Price Monitoring Extn
10th Jul 20184:35 pmRNSPrice Monitoring Extension
28th Jun 201812:16 pmRNSResult of AGM
14th Jun 20187:00 amRNSResults of CIDP Pre-Clinical Data
6th Jun 20187:00 amRNSNotice of AGM & Posting of Annual Report
29th May 20187:00 amRNSUpdate on Pivotal Phase III Trial of Lupuzor
29th May 20187:00 amRNSFinal Results
24th Apr 201811:59 amRNSHolding(s) in Company
20th Apr 20188:24 amRNSHolding(s) in Company
19th Apr 20188:05 amRNSHolding(s) in Company
17th Apr 20187:00 amRNSTopline results of Lupuzor Pivotal Phase III Trial
28th Mar 20187:00 amRNSAppointment of Joint Broker
23rd Mar 20187:00 amRNSLupuzor Pivotal Phase III Study Update
5th Mar 20184:13 pmRNSAIM Notice (17)
15th Feb 20187:00 amRNSLondon Investor Evening
9th Feb 20182:00 pmRNSHolding(s) in Company
7th Feb 20189:35 amRNSHolding(s) in Company
5th Feb 20187:00 amRNSHolding(s) in Company
31st Jan 201810:23 amRNSHolding(s) in Company
24th Jan 20187:00 amRNSSuccessful Placing to Raise £10 Million
18th Jan 20187:00 amRNSCompletion of LupuzorT Pivotal Phase III Study
21st Dec 20177:05 amRNSGrant of Options
21st Dec 20177:00 amRNSLast patient completes dosing in LupuzorT Trial
28th Nov 201712:00 pmRNSHolding(s) in Company
24th Nov 20171:32 pmRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.